These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11060540)

  • 21. Lack of association between valproic acid response and polymorphisms of its metabolism, transport, and receptor genes in children with focal seizures.
    Feng W; Mei S; Han J; Zhu L; Yu Y; Gao B; Wu Y; Li J; Zhao Z; Fang F
    Neurol Sci; 2019 Mar; 40(3):523-528. PubMed ID: 30564963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid.
    Meral C; Cekmez F; Vurucu S; Tascılar E; Pirgon O; Canpolat FE; Ipcioglu OM; Aydemir G; Aydınoz S
    Eur Cytokine Netw; 2011 Jun; 22(2):118-22. PubMed ID: 21669562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe bleeding complications during antiepileptic treatment with valproic acid in children.
    Cannizzaro E; Albisetti M; Wohlrab G; Schmugge M
    Neuropediatrics; 2007 Feb; 38(1):42-5. PubMed ID: 17607605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible dementia and gait disturbance after prolonged use of valproic acid.
    Evans MD; Shinar R; Yaari R
    Seizure; 2011 Jul; 20(6):509-11. PubMed ID: 21435910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G; Caksen H; Içağasioğlu D
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old].
    Motte J; Pedespan JM; Sevestre M; Chiron C;
    Arch Pediatr; 2005 Oct; 12(10):1533-9. PubMed ID: 16099147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the immunosuppressive effect of some anticonvulsants in children].
    Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L
    Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 37. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of chronic pancreatic insufficiency due to valproic acid in a child.
    Cooper MA; Groll A
    Can J Gastroenterol; 2001 Feb; 15(2):127-30. PubMed ID: 11240383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
    Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
    J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.